POTENT, ORALLY-ACTIVE CARBOXYLATE REPLACEMENT ANALOGS OF THE ENDOTHELIN RECEPTOR ANTAGONIST L-749,329

被引：0
|
作者：
FITCH, KJ
WALSH, TF
TOUPENCE, RB
WILLIAMS, DL
NOLAN, NA
OBRIEN, JA
PETTIBONE, DJ
KIVLIGHN, SD
KRAUSE, SM
CLAYTON, FC
ZINGARO, GJ
SIEGL, PKS
GREENLEE, WJ
机构：
[1] MERCK SHARP & DOHME RES LABS,DEPT PHARMACOL,RAHWAY,NJ 07065
[2] MERCK SHARP & DOHME RES LABS,DEPT EXPLORATORY CHEM,RAHWAY,NJ 07065
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1995年 / 209卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：162 / MEDI
相关论文
共 50 条
  • [21] BOSENTAN, AN ORALLY-ACTIVE ENDOTHELIN ANTAGONIST - EFFECT ON THE RENAL RESPONSE TO CONTRAST-MEDIA
    OLDROYD, SD
    HAYLOR, JL
    MORCOS, SK
    RADIOLOGY, 1995, 196 (03) : 661 - 665
  • [22] METIAMIDE - AN ORALLY-ACTIVE HISTAMINE H-2-RECEPTOR ANTAGONIST
    BLACK, JW
    DUNCAN, WAM
    EMMETT, JC
    GANELLIN, CR
    HESSELBO, T
    PARSONS, ME
    WYLLIE, JH
    AGENTS AND ACTIONS, 1994, 43 (3-4): : 91 - 96
  • [23] GR127935 - A POTENT ORALLY-ACTIVE 5-HT(1D) RECEPTOR ANTAGONIST
    SKINGLE, M
    SCOPES, DIC
    FENIUK, W
    CONNOR, HE
    CARTER, MC
    CLITHEROW, JW
    TYERS, MB
    BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 : P9 - P9
  • [24] AQUARETIC EFFECT OF A POTENT, ORALLY-ACTIVE, NONPEPTIDE V-2 ANTAGONIST IN MEN
    OHNISHI, A
    ORITA, Y
    TAKAGI, N
    FUJITA, T
    TOYOKI, T
    IHARA, Y
    YAMAMURA, Y
    INOUE, T
    TANAKA, T
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1995, 272 (02): : 546 - 551
  • [25] DISCOVERY OF A-85783, A POTENT, ORALLY-ACTIVE ANTAGONIST OF PLATELET-ACTIVATING-FACTOR
    HOLMS, JH
    DAVIDSEN, SK
    SHEPPARD, GS
    CURTIN, ML
    CARRERA, GM
    HEYMAN, HR
    PIREH, D
    ALBERT, DH
    CONWAY, RG
    MAGOC, TJ
    RHEIN, DA
    TAPANG, P
    SUMMERS, JB
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 176 - MEDI
  • [26] Antihypertensive efficacy of J-104,132 (L753,037), a potent, orally-active, mixed ETA/ETB endothelin receptor antagonist, in conscious, DOCA/salt hypertensive rats
    Gabel, R
    Zingaro, G
    Nishikibe, M
    Kivlighn, S
    Siegl, P
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R269 - R269
  • [27] PHARMACOLOGICAL PROFILE OF VALSARTAN - A POTENT, ORALLY-ACTIVE, NONPEPTIDE ANTAGONIST OF THE ANGIOTENSIN-II AT1-RECEPTOR SUBTYPE
    CRISCIONE, L
    DEGASPARO, M
    BUHLMAYER, P
    WHITEBREAD, S
    RAMJOUE, HPR
    WOOD, J
    BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (02) : 761 - 771
  • [28] PHARMACOLOGICAL CHARACTERIZATION OF PD-156707, AN ORALLY-ACTIVE ET(A) RECEPTOR ANTAGONIST
    REYNOLDS, EE
    KEISER, JA
    HALEEN, SJ
    WALKER, DM
    OLSZEWSKI, B
    SCHROEDER, RL
    TAYLOR, DG
    HWANG, O
    WELCH, KM
    FLYNN, MA
    THOMPSON, DM
    EDMUNDS, JJ
    BERRYMAN, KA
    PLUMMER, M
    CHENG, XM
    PATT, WC
    DOHERTY, AM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1995, 273 (03): : 1410 - 1417
  • [29] NOVEL FLUOROPROSTACYCLIN ANALOGS WITH MODIFIED CYCLOALKYLENYL CHAINS - HIGHLY POTENT AND ORALLY-ACTIVE ANTIANGINAL AGENTS
    MATSUMURA, Y
    ASAI, T
    SHIMADA, T
    NAKAYAMA, T
    URUSHIHARA, M
    MORIZAWA, Y
    YASUDA, A
    YAMAMOTO, T
    FUJITANI, B
    HOSOKI, K
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1995, 43 (02) : 353 - 355
  • [30] ARYL AMIDINES - A NEW CLASS OF POTENT ORALLY-ACTIVE LEUKOTRIENE-B4 ANTAGONIST
    MAIN, AJ
    BARSKY, LI
    MORRISSEY, M
    CADILLA, R
    BOEHM, C
    ZHANG, YC
    SUH, HS
    BOXER, JB
    POWERS, DB
    FUJIMOTO, RA
    DOTI, RA
    HEALY, CT
    SELIGMANN, BE
    UZIELFUSI, S
    JARVIS, MF
    SILLS, MA
    JACKSON, RH
    LIPSON, KE
    CHIN, MH
    PELLAS, TC
    PASTOR, G
    FRYER, LR
    RAYCHAUDHURI, AA
    KOTYUK, BL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 3 - MEDI
12345